Azurity Pharmaceuticals, Inc. Sustainability Profile
Azurity Pharmaceuticals, Inc., headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in the development and commercialisation of innovative medicines. Founded in 2018, the company has quickly established itself as a leader in providing unique formulations tailored for patients with specific needs, particularly in the paediatric and rare disease sectors. With a focus on high-quality, patient-centric products, Azurity's core offerings include specialised oral liquid medications that address significant gaps in treatment options. The company’s commitment to enhancing patient outcomes through customised solutions sets it apart in a competitive market. Notable achievements include rapid growth and recognition for its contributions to improving access to essential therapies, solidifying Azurity's position as a trusted name in the pharmaceutical landscape.
DitchCarbon Score
How does Azurity Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Azurity Pharmaceuticals, Inc.'s score of 28 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Azurity Pharmaceuticals, Inc.'s reported carbon emissions
Azurity Pharmaceuticals, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi). As there are no emissions data or reduction initiatives available, it is unclear how Azurity Pharmaceuticals is addressing its carbon footprint or contributing to climate action within the pharmaceutical industry. The lack of reported emissions and commitments suggests an opportunity for the company to enhance its sustainability efforts and align with industry standards for climate responsibility.
How Carbon Intensive is Azurity Pharmaceuticals, Inc.'s Industry?
How Carbon Intensive is Azurity Pharmaceuticals, Inc.'s Location?
Azurity Pharmaceuticals, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Azurity Pharmaceuticals, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
